Biosensor for determining an analyte concentration Patent Grant Beer , et al. September 4, 2 [Ascensia Diabetes Care Holdings AG]

Biosensor for determining an analyte concentration

Beer , et al. September 4, 2

Patent Grant 10067082

U.S. patent number 10,067,082 [Application Number 15/197,187] was granted by the patent office on 2018-09-04 for biosensor for determining an analyte concentration. This patent grant is currently assigned to Ascensia Diabetes Care Holdings AG. The grantee listed for this patent is Ascensia Diabetes Care Holdings AG. Invention is credited to Greg P. Beer, Huan-Ping Wu, Kin-Fai Yip.

United States Patent	10,067,082
Beer , et al.	September 4, 2018

Biosensor for determining an analyte concentration

Abstract

A biosensor (102) for determining the presence or amount of a substance in a sample and methods of use of the biosensor (102) are provided. The biosensor (102) for receiving a user sample to be analyzed includes a mixture for electrochemical reaction with an analyte. The mixture includes an enzyme, a mediator and an oxidizable species as an internal reference.

Inventors:

Beer; Greg P. (Fairfield, CA), Wu; Huan-Ping (Granger, IN), Yip; Kin-Fai (Pittsburgh, PA)

Applicant:

Name	City	State	Country	Type
Ascensia Diabetes Care Holdings AG	Basel	N/A	CH

Assignee:

Ascensia Diabetes Care Holdings AG (Basel, CH)

Family ID:

34860292

Appl. No.:

15/197,187

Filed:

June 29, 2016

Prior Publication Data


	Document Identifier	Publication Date
	US 20160313272 A1	Oct 27, 2016

Related U.S. Patent Documents


Application Number	Filing Date	Patent Number	Issue Date
14193214	Feb 28, 2014	9410917
10590765	Apr 15, 2014	8696880
PCT/US2005/003622	Feb 4, 2005
60542362	Feb 6, 2004

Current U.S. Class:	1/1
Current CPC Class:	G01N 27/3274 (20130101); C12Q 1/004 (20130101); G01N 33/54373 (20130101); G01N 27/3273 (20130101); G01N 27/3271 (20130101); C12Q 1/006 (20130101); G01N 27/3272 (20130101)
Current International Class:	G01N 33/487 (20060101); G01N 27/327 (20060101); C12Q 1/00 (20060101); G01N 33/543 (20060101)
Field of Search:	;204/403.01-403.15 ;205/777.5

References Cited [Referenced By]

U.S. Patent Documents


3420205	January 1969	Morrison
3505136	April 1970	Attwood
3510268	May 1970	Hach
3551295	December 1970	Dyer
3573139	March 1971	Mori et al.
3621381	November 1971	Eckfeldt
3715192	February 1973	Wenz et al.
3720093	March 1973	Gill
3763422	October 1973	MacPhee et al.
3770607	November 1973	Williams
3776832	December 1973	Oswin et al.
3791933	February 1974	Moyer et al.
3791988	February 1974	Bauer et al.
3838033	September 1974	Mindt et al.
3902970	September 1975	Levin
3917453	November 1975	Milligan et al.
3919627	November 1975	Allen
3920580	November 1975	Mast
3925183	December 1975	Oswin et al.
3937615	February 1976	Clack et al.
3948745	April 1976	Guillbault et al.
3980437	September 1976	Kishimoto et al.
4005002	January 1977	Racine et al.
4008448	February 1977	Muggli
4040908	August 1977	Clark, Jr.
4053381	October 1977	Hamblen et al.
4065263	December 1977	Woodbridge et al.
4077861	March 1978	Lauer
4123701	October 1978	Josefsen et al.
4127448	November 1978	Schick et al.
4137495	January 1979	Brown
4184936	January 1980	Paul et al.
4214968	July 1980	Battaglia et al.
4217196	August 1980	Huch
4224125	September 1980	Nakamura et al.
4225410	September 1980	Pace et al.
4229426	October 1980	Haagensen, Jr.
4230537	October 1980	Delente et al.
4233029	November 1980	Columbus
4260680	April 1981	Muramatsu et al.
4263343	April 1981	Kim
4265250	May 1981	Parker
4273639	June 1981	Gottermeier
4297184	October 1981	Dyer
4297569	October 1981	Flies
4301412	November 1981	Hill et al.
4303887	December 1981	Hill et al.
4304853	December 1981	Jozefonvicz et al.
4323536	April 1982	Columbus
4329642	May 1982	Luthi et al.
4366033	December 1982	Richter et al.
4376689	March 1983	Nakamura et al.
4381775	May 1983	Nose et al.
4396464	August 1983	Giner et al.
4402940	September 1983	Nose et al.
4403984	September 1983	Ash et al.
4407290	October 1983	Wiber
4407959	October 1983	Tsuji et al.
4413407	November 1983	Columbus
4420564	December 1983	Tsuji et al.
4431004	February 1984	Bessman et al.
4436094	March 1984	Cerami
4440175	April 1984	Wilkins
4473457	September 1984	Columbus
4476149	October 1984	Poppe et al.
4477314	October 1984	Richter et al.
4477575	October 1984	Vogel
4490216	December 1984	McConnell
4499423	February 1985	Matthiessen
4502938	March 1985	Covington et al.
4517291	May 1985	Seago
4545382	October 1985	Higgins et al.
4547735	October 1985	Kiesewetter et al.
4552458	November 1985	Lowne
4561944	December 1985	Sasaki et al.
4571292	February 1986	Liu et al.
4572899	February 1986	Walker et al.
4578716	March 1986	Van Rijckevorsel et al.
4579893	April 1986	Wang et al.
4582684	April 1986	Vogel et al.
4591550	May 1986	Hafeman et al.
4628193	December 1986	Blum
4642295	February 1987	Baker
4648665	March 1987	Davis et al.
4652830	March 1987	Brown
4654197	March 1987	Lilja et al.
4671288	June 1987	Gough
4676653	June 1987	Strohmeier et al.
4679562	July 1987	Luksha
4680268	July 1987	Clark, Jr.
4682602	July 1987	Prohaska
4686479	August 1987	Young et al.
4703017	October 1987	Campbell et al.
4703756	November 1987	Gough et al.
4713347	December 1987	Mitchell et al.
4714874	December 1987	Morris et al.
4721677	January 1988	Clark, Jr.
4729959	March 1988	Ryan
4731726	March 1988	Allen et al.
4734184	March 1988	Burleigh et al.
4745076	May 1988	Muller et al.
4746607	May 1988	Mura et al.
4750496	June 1988	Reinhart et al.
4759828	July 1988	Young et al.
4795542	January 1989	Ross et al.
4797256	January 1989	Watlington, IV
4805624	February 1989	Yao et al.
4806311	February 1989	Greenquist
4806312	February 1989	Greenquist
4810203	March 1989	Komatsu
4816224	March 1989	Vogel et al.
4820399	April 1989	Senda et al.
4820636	April 1989	Hill et al.
4830959	May 1989	McNeil et al.
4832814	May 1989	Root
4834234	May 1989	Sacherer et al.
4849330	July 1989	Humphries et al.
4854153	August 1989	Miyagawa et al.
4865873	September 1989	Cole, Jr. et al.
4877580	October 1989	Aronowitz et al.
4890926	January 1990	Dosmann et al.
4894137	January 1990	Takizawa et al.
4897162	January 1990	Lewandoski et al.
4919770	April 1990	Preidel et al.
4927516	May 1990	Yamaqucji et al.
4929330	May 1990	Osaka et al.
4929545	May 1990	Freitag
4935105	June 1990	Churchouse
4935106	June 1990	Liston et al.
4936346	June 1990	Kugler
4938860	July 1990	Wogoman
4940945	July 1990	Littlejohn et al.
4954087	September 1990	Lauks et al.
4956275	September 1990	Zuk et al.
4963814	October 1990	Parks et al.
4970145	November 1990	Bennetto et al.
4975647	December 1990	Downer et al.
4976724	December 1990	Nieto
4999582	March 1991	Parks et al.
4999632	March 1991	Parks
5018164	May 1991	Brewer et al.
5019974	May 1991	Beckers
5028542	July 1991	Kennamer et al.
5035862	July 1991	Dietze et al.
5039618	August 1991	Stone
5046618	September 1991	Wood
5049487	September 1991	Phillips et al.
5057447	October 1991	Paterson et al.
5059199	October 1991	Okada et al.
5059394	October 1991	Phillips et al.
5066372	November 1991	Weetall
5075077	December 1991	Durley, III et al.
5096669	March 1992	Lauks et al.
5096671	March 1992	Kane et al.
5108564	April 1992	Szuminsky et al.
5108819	April 1992	Heller et al.
5112455	May 1992	Cozzette et al.
5112758	May 1992	Fellman et al.
5118183	June 1992	Cargill et al.
5120420	June 1992	Nankai et al.
5120421	June 1992	Glass et al.
5122244	June 1992	Hoenes et al.
5128015	July 1992	Szuminsky et al.
5140176	August 1992	Okino
5141850	August 1992	Cole et al.
5141868	August 1992	Shanks et al.
5143694	September 1992	Schafer et al.
5155628	October 1992	Dosmann
5179005	January 1993	Phillips et al.
5179288	January 1993	Miffitt et al.
5182707	January 1993	Cooper et al.
5187100	February 1993	Matzinger et al.
5192415	March 1993	Yosioka et al.
5202261	April 1993	Musho et al.
5206147	April 1993	Hoenes
5217594	June 1993	Henkens et al.
5220920	June 1993	Gharib
5223117	June 1993	Wrighton et al.
5229282	July 1993	Yoshioka et al.
5232516	August 1993	Hed
5232667	August 1993	Hieb et al.
5232668	August 1993	Grante et al.
5234813	August 1993	MeGreenhan et al.
5243516	September 1993	White
5246858	September 1993	Arbuckle et al.
5250439	October 1993	Mucho et al.
5261411	November 1993	Hughes et al.
5262035	November 1993	Gregg et al.
5264103	November 1993	Yoshioka et al.
5264104	November 1993	Gregg et al.
5266179	November 1993	Nanki et al.
5269891	December 1993	Colin
5279294	January 1994	Anderson et al.
5281395	January 1994	Markart et al.
5282950	February 1994	Dietze et al.
5284770	February 1994	Adrain et al.
5286362	February 1994	Hoenes et al.
5288387	February 1994	Ito et al.
5288636	February 1994	Pollmann et al.
5304468	April 1994	Phillips et al.
5306623	April 1994	Kiser et al.
5311426	May 1994	Donohue et al.
5312590	May 1994	Gunasingham
5320725	June 1994	Gregg et al.
5320732	June 1994	Nankai et al.
5321492	June 1994	Detwiler et al.
5332479	July 1994	Uenoyama et al.
5334296	August 1994	Henkens et al.
5344754	September 1994	Zewing
5352351	October 1994	White et al.
5353351	October 1994	Bartoli et al.
5354447	October 1994	Uenoyama et al.
5356786	October 1994	Heller et al.
5361314	November 1994	Kopelman et al.
5366609	November 1994	White et al.
5368707	November 1994	Henkens et al.
5371687	December 1994	Holmes, II et al.
5376254	December 1994	Fisher
5379214	January 1995	Arbuckle et al.
5384028	January 1995	Ito
5385846	January 1995	Kuhn et al.
5389215	February 1995	Horiuchi et al.
5391272	February 1995	O'Daly et al.
5393903	February 1995	Gratzel et al.
5395504	March 1995	Saurer et al.
5403462	April 1995	Lev et al.
5405511	April 1995	White et al.
5410059	April 1995	Fraser et al.
5410474	April 1995	Fox
5411647	May 1995	Johnson et al.
5413690	May 1995	Kost et al.
5413764	May 1995	Haar
5418142	May 1995	Kiser et al.
5421189	May 1995	Dussault
5424035	June 1995	Hones et al.
5426032	June 1995	Phillips et al.
5427912	June 1995	Brown et al.
5429735	July 1995	Johnson et al.
5437772	August 1995	DeCastro et al.
5437999	August 1995	Diebold et al.
5438271	August 1995	White et al.
5439826	August 1995	Kontorovich
5445967	August 1995	Deuter
5447837	September 1995	Urnovitz
5449898	September 1995	Dosmann
5453360	September 1995	Yu
5468366	November 1995	Wegner et al.
5469846	November 1995	Khan
5470533	November 1995	Shindo et al.
5477326	December 1995	Dosmann
5489414	February 1996	Schreiber et al.
5494638	February 1996	Gullick
5500350	March 1996	Baker et al.
5502396	March 1996	Desarzens et al.
5504011	April 1996	Gavin et al.
5508171	April 1996	Walling et al.
5508200	April 1996	Tiffany et al.
5508203	April 1996	Fuller et al.
5509410	April 1996	Hill et al.
5512159	April 1996	Yoshioka et al.
5515847	May 1996	Braig et al.
5518689	May 1996	Dosmann et al.
5520786	May 1996	Bloczynski et al.
5526111	June 1996	Collins et al.
5526120	June 1996	Jina et al.
5526808	June 1996	Kaminsky et al.
5532128	July 1996	Eggers et al.
5545519	August 1996	Vadgama et al.
5552116	September 1996	Yokota et al.
5554531	September 1996	Zweig
5556789	September 1996	Goerlach-Graw et al.
5563031	October 1996	Yu
5563042	October 1996	Phillips et al.
5569591	October 1996	Kell et al.
5569608	October 1996	Sommer
5572159	November 1996	McFarland
5575403	November 1996	Charlton et al.
5575895	November 1996	Ikeda et al.
5576073	November 1996	Kickelhain
5580794	December 1996	Allen
5582697	December 1996	Ikeda et al.
5589045	December 1996	Hyodo
5589326	December 1996	Deng et al.
5593390	January 1997	Castellano et al.
5593739	January 1997	Kickelhain
5594906	January 1997	Holmes, II et al.
5597532	January 1997	Connolly
5603820	February 1997	Malinski et al.
5604110	February 1997	Baker et al.
5605662	February 1997	Heller et al.
5605837	February 1997	Karimi et al.
5611909	March 1997	Studer
5611999	March 1997	Dosmann et al.
5620579	April 1997	Genshaw et al.
5620863	April 1997	Tomasco et al.
5620890	April 1997	Kamps-Holtzapple et al.
5627922	May 1997	Kopelman et al.
5628890	May 1997	Carter et al.
5630986	May 1997	Charlton et al.
5635362	June 1997	Levine et al.
5635364	June 1997	Clark et al.
5639671	June 1997	Bogart et al.
5642734	July 1997	Ruben et al.
5644501	July 1997	Lin et al.
5645798	July 1997	Schreiber et al.
5650061	July 1997	Kuhr et al.
5650062	July 1997	Ikeda et al.
5653863	August 1997	Genshaw et al.
5654178	August 1997	Fitzpatrick et al.
5656502	August 1997	Mackay et al.
5658443	August 1997	Yamamoto et al.
5658802	August 1997	Hayes et al.
5660791	August 1997	Brenneman et al.
5665215	September 1997	Bussmann et al.
5670031	September 1997	Hintsche et al.
5682884	November 1997	Hill et al.
5686659	November 1997	Neel et al.
5691486	November 1997	Behringer et al.
5691633	November 1997	Liu et al.
5695623	December 1997	Michel et al.
5695947	December 1997	Guo et al.
5698083	December 1997	Glass
5700695	December 1997	Yassinzadeh et al.
5701181	December 1997	Boiarski et al.
5704354	January 1998	Preidel et al.
5708247	January 1998	McAleer et al.
5710011	January 1998	Forrow et al.
5710622	January 1998	Neel et al.
5719667	February 1998	Miers
5720862	February 1998	Hamamoto et al.
5723284	March 1998	Ye
5723345	March 1998	Yamauchi et al.
5727548	March 1998	Hill et al.
5728074	March 1998	Castellano et al.
5745308	April 1998	Spangenberg et al.
5748002	May 1998	Scott et al.
5755953	May 1998	Henning et al.
5757666	May 1998	Schreiber et al.
5759364	June 1998	Charlton et al.
5759794	June 1998	Levine et al.
5762770	June 1998	Pritchard et al.
5776710	July 1998	Levine et al.
5780304	July 1998	Matzinger et al.
5786584	July 1998	Button et al.
5788833	August 1998	Lewis et al.
5789255	August 1998	Yu
5792668	August 1998	Fuller et al.
5798031	August 1998	Charlton et al.
5801057	September 1998	Smart et al.
5807375	September 1998	Gross et al.
5820551	October 1998	Hill et al.
5820662	October 1998	Kubo et al.
5832921	November 1998	Lennert et al.
5834217	November 1998	Levine et al.
5837546	November 1998	Allen et al.
5843691	December 1998	Douglas et al.
5843692	December 1998	Phillips et al.
5846794	December 1998	Delobeau et al.
5849174	December 1998	Sanghera et al.
5856195	January 1999	Charlton et al.
5863400	January 1999	Drummond et al.
5873990	February 1999	Wojciechowski et al.
5874046	February 1999	Megerle et al.
5883378	March 1999	Irish et al.
5885839	March 1999	Lingane et al.
5890489	April 1999	Elden
5904898	May 1999	Market
5911872	June 1999	Lewis et al.
5916156	June 1999	Hildenbrand et al.
5921925	July 1999	Cartmell et al.
5922530	July 1999	Yu
5922591	July 1999	Anderson et al.
5925021	July 1999	Castellano et al.
RE36268	August 1999	Szuminsky et al.
5942102	August 1999	Hodges et al.
5945341	August 1999	Howard, III
5948289	September 1999	Noda et al.
5958199	September 1999	Miyamto et al.
5965380	October 1999	Heller et al.
5968760	October 1999	Phillips et al.
5971923	October 1999	Finger
5989917	November 1999	McAleer et al.
6001239	December 1999	Douglas et al.
6004441	December 1999	Fujiwara et al.
6004442	December 1999	Choulga et al.
6013170	January 2000	Meade
6033866	March 2000	Guo et al.
6042714	March 2000	Lin et al.
6044285	March 2000	Chaiken et al.
6045567	April 2000	Taylor et al.
6054039	April 2000	Shieh
6061128	May 2000	Zweig et al.
6069011	May 2000	Riedel
6071391	June 2000	Gotoh et al.
6087182	July 2000	Jeng et al.
6091975	July 2000	Daddona et al.
6102872	August 2000	Doneen et al.
6103033	August 2000	Say et al.
6103509	August 2000	Sode
6110354	August 2000	Saban et al.
6120676	September 2000	Heller et al.
6121009	September 2000	Heller et al.
6121050	September 2000	Han
6126609	October 2000	Keith et al.
6128519	October 2000	Say
6129823	October 2000	Hughes et al.
6134461	October 2000	Say et al.
6136549	October 2000	Feistel
6136610	October 2000	Polito et al.
6143164	November 2000	Heller et al.
6143247	November 2000	Sheppard, Jr. et al.
6144869	November 2000	Berner et al.
6150124	November 2000	Riedel
6153069	November 2000	Pottgen et al.
6156051	December 2000	Schraga
6156173	December 2000	Gotoh et al.
6156673	December 2000	Hintermaier et al.
6157442	December 2000	Raskas
6157472	December 2000	Eum et al.
6159745	December 2000	Roberts et al.
6162611	December 2000	Heller et al.
6162639	December 2000	Douglas
6168563	January 2001	Brown
6168957	January 2001	Matzinger et al.
6170318	January 2001	Lewis
6174420	January 2001	Hodges et al.
6175752	January 2001	Say et al.
6176988	January 2001	Kessler
6179979	January 2001	Hodges et al.
6180062	January 2001	Naka et al.
6181417	January 2001	Dosmann
6193873	February 2001	Oharra et al.
6197040	March 2001	LeVaughn et al.
6200773	March 2001	Ouyang et al.
6201607	March 2001	Roth et al.
6203952	March 2001	O'Brian et al.
6206282	March 2001	Hayes, Sr. et al.
6206292	March 2001	Roberts et al.
6207000	March 2001	Schwobel et al.
6212417	April 2001	Ikeda et al.
6218571	April 2001	Zhena et al.
6225078	May 2001	Ikeda et al.
6226081	May 2001	Fantone et al.
6233471	May 2001	Berner et al.
6241862	June 2001	McAlleer et al.
6246862	June 2001	Grivas et al.
6246966	June 2001	Perry
6251260	June 2001	Heller et al.
6258229	July 2001	Winarta et al.
6259937	July 2001	Schulman et al.
6261519	July 2001	Harding et al.
6262749	July 2001	Finger et al.
6268162	July 2001	Phillips et al.
6270637	August 2001	Crismore et al.
6271044	August 2001	Ballerstadt et al.
6272262	August 2001	Kopelman et al.
6272364	August 2001	Kurnok
6275717	August 2001	Gross et al.
6277641	August 2001	Yager
6281006	August 2001	Heller et al.
6284125	September 2001	Hodges et al.
6284550	September 2001	Carroll et al.
6287451	September 2001	Winarta et al.
6287595	September 2001	Loewy et al.
6294062	September 2001	Buck et al.
6294281	September 2001	Heller
6294787	September 2001	Schieferdecker et al.
6295506	September 2001	Heinonen et al.
6297697	October 2001	Delano et al.
6299757	October 2001	Feldman et al.
6300123	October 2001	Vadgama et al.
6300961	October 2001	Finger et al.
6309526	October 2001	Fujiwara et al.
6315951	November 2001	Markart
6316264	November 2001	Corey et al.
6326160	December 2001	Dunn et al.
6329161	December 2001	Heller et al.
6330464	December 2001	Colvin, Jr. et al.
6335203	January 2002	Patel et al.
6338790	January 2002	Feldman et al.
6340428	January 2002	Ikeada et al.
6342364	January 2002	Watanabe et al.
6344133	February 2002	Formica et al.
6349230	February 2002	Kawanaka et al.
6358752	March 2002	Durst et al.
6377896	April 2002	Sato et al.
6379513	April 2002	Chambers et al.
6389891	May 2002	D'Angelico et al.
6391558	May 2002	Henkens et al.
6391645	May 2002	Huang et al.
6394952	May 2002	Anderson et al.
6395227	May 2002	Kiser et al.
6399258	June 2002	O'Brien et al.
6401532	June 2002	Lubbers
6413398	July 2002	Gerhardt et al.
6413411	July 2002	Pottgen et al.
6414213	July 2002	Ohmori et al.
6414395	July 2002	Ookuma et al.
6414410	July 2002	Nakamura et al.
6420128	July 2002	Ouyang et al.
6444115	September 2002	Hodges et al.
6447657	September 2002	Bhullar et al.
6454921	September 2002	Hodges et al.
6461496	October 2002	Feldman et al.
6475372	November 2002	Ohara et al.
6484046	November 2002	Say et al.
6485923	November 2002	Yani et al.
6488827	December 2002	Shartle
6489133	December 2002	Phillips et al.
6491803	December 2002	Shen et al.
6491870	December 2002	Patel et al.
6501976	December 2002	Sohrab
6503381	January 2003	Gotoh et al.
6512986	January 2003	Harmon
6514718	February 2003	Heller et al.
6521110	February 2003	Hodges et al.
6521182	February 2003	Shartle et al.
6525330	February 2003	Paolini et al.
6525549	February 2003	Poellmann
6526298	February 2003	Khalil et al.
6531040	March 2003	Musho et al.
6531239	March 2003	Heller
6531322	March 2003	Jurik et al.
6535753	March 2003	Raskas
6537498	March 2003	Lewis et al.
6538735	March 2003	Duebendorfer et al.
6540890	April 2003	Bhullar et al.
6540891	April 2003	Stewart et al.
6541266	April 2003	Modzelewski et al.
6544474	April 2003	Douglas et al.
6549796	April 2003	Sohrab
6551494	April 2003	Heller et al.
6555061	April 2003	Leong et al.
6558528	May 2003	Matzinger
6558529	May 2003	McVey et al.
6560471	May 2003	Heller et al.
6562625	May 2003	Modzelewski et al.
6565509	May 2003	Say et al.
6565738	May 2003	Henning et al.
6570390	May 2003	Hirayama et al.
6571651	June 2003	Hodges
6572822	June 2003	Jurki et al.
6574425	June 2003	Weiss et al.
6576101	June 2003	Heller et al.
6576416	June 2003	Haviland et al.
6576461	June 2003	Heller et al.
6579690	June 2003	Bonnecaze
6591125	July 2003	Buse et al.
6592744	July 2003	Hodges et al.
6592745	July 2003	Feldmen et al.
6594514	July 2003	Berner et al.
6599407	July 2003	Taniike et al.
6600997	July 2003	Deweese et al.
6605200	August 2003	Mao et al.
6605201	August 2003	Mao et al.
6607658	August 2003	Heller et al.
6616819	September 2003	Liamos
6618934	September 2003	Feldmen et al.
6623501	September 2003	Heller et al.
6627057	September 2003	Bullar et al.
6632349	October 2003	Hodges et al.
6636652	October 2003	Kopelman et al.
6638415	October 2003	Hodges et al.
6638716	October 2003	Heller et al.
6645359	November 2003	Bhullar et al.
6645368	November 2003	Beaty et al.
6654625	November 2003	Say et al.
6656702	December 2003	Yugawa et al.
6676816	January 2004	Mao et al.
6676995	January 2004	Dick et al.
6689265	February 2004	Heller et al.
6689411	February 2004	Dick et al.
6690836	February 2004	Natarajan et al.
6699384	March 2004	Lin et al.
6749740	June 2004	Liamos et al.
6767441	July 2004	Cai et al.
6790341	September 2004	Saba et al.
6824670	November 2004	Tokunaga et al.
6841052	January 2005	Musho et al.
6890421	May 2005	Oharra et al.
6893545	May 2005	Gotoh et al.
6942518	September 2005	Liamos et al.
7018843	March 2006	Heller
7122111	October 2006	Tokunaga et al.
7132041	November 2006	Deng et al.
7276146	October 2007	Wilsey
7351323	April 2008	Iketaki et al.
8026104	September 2011	Wu et al.
8088272	January 2012	Deng
8101062	January 2012	Deng
8147674	April 2012	Wu
8234076	July 2012	Carpenter
8262899	September 2012	Wu
8287717	October 2012	Wu
8404100	March 2013	Wu
8425757	April 2013	Wu et al.
8470604	June 2013	Wu et al.
2001/0000129	April 2001	Raskas
2001/0006149	July 2001	Taniike et al.
2001/0017269	August 2001	Heller et al.
2001/0042683	November 2001	Musho et al.
2001/0052470	December 2001	Hodges et al.
2002/0004106	January 2002	Leddy et al.
2002/0012821	January 2002	Leddy et al.
2002/0053523	May 2002	Liamos et al.
2002/0079219	June 2002	Zhao et al.
2002/0081588	June 2002	De Lumley-Woodyear et al.
2002/0084196	July 2002	Liamos et al.
2002/0125146	September 2002	Chan et al.
2002/0139692	October 2002	Tokunaga et al.
2002/0157967	October 2002	Ling et al.
2002/0180446	December 2002	Kuhr et al.
2002/0185375	December 2002	Wogoman
2003/0064525	April 2003	Liess
2003/0113933	June 2003	Jansson et al.
2003/0119208	June 2003	Yoon et al.
2003/0136673	July 2003	Pilloud et al.
2003/0146110	August 2003	Karinka et al.
2003/0148169	August 2003	Willmer et al.
2003/0149348	August 2003	Raskas
2003/0159927	August 2003	Lewis et al.
2003/0159945	August 2003	Miyazaki
2003/0175737	September 2003	Schulien et al.
2003/0175841	September 2003	Watanabe
2003/0176183	September 2003	Drucker et al.
2003/0178322	September 2003	Bolon
2003/0199744	October 2003	Buse et al.
2003/0201194	October 2003	Heller et al.
2003/0205465	November 2003	Feng et al.
2003/0209450	November 2003	McVey et al.
2004/0005716	January 2004	Beaty et al.
2004/0007461	January 2004	Edelbrock
2004/0026253	February 2004	Leddy et al.
2004/0033165	February 2004	Lewis et al.
2004/0040840	March 2004	Mao et al.
2004/0045821	March 2004	Cui et al.
2004/0054267	March 2004	Feldmen et al.
2004/0055898	March 2004	Heller et al.
2004/0060818	April 2004	Feldmen et al.
2004/0061841	April 2004	Black et al.
2004/0074772	April 2004	Kumar et al.
2004/0079653	April 2004	Karinka et al.
2004/0099531	May 2004	Srinivasan et al.
2004/0118682	June 2004	Murray et al.
2004/0149577	August 2004	Kumar et al.
2004/0157337	August 2004	Burke et al.
2004/0157338	August 2004	Burke et al.
2004/0157339	August 2004	Burke et al.
2004/0180444	September 2004	Rannikko et al.
2004/0224137	November 2004	Rogalska et al.
2004/0225230	November 2004	Liamos et al.
2004/0245121	December 2004	Nagakawa et al.
2004/0253367	December 2004	Wogoman
2004/0256248	December 2004	Burke et al.
2004/0259180	December 2004	Burke et al.
2004/0260511	December 2004	Burke et al.
2005/0009126	January 2005	Andrews et al.
2005/0049473	March 2005	Desai et al.
2005/0069892	March 2005	Lyengar et al.
2005/0164322	July 2005	Heller et al.
2005/0176153	August 2005	O'hara et al.
2005/0247562	November 2005	Tokunaga et al.
2006/0063218	March 2006	Bartkowiak et al.
2006/0074564	April 2006	Bartkowiak et al.
2006/0085137	April 2006	Bartkowiak et al.
2006/0191787	August 2006	Wang et al.
2007/0074977	April 2007	Guo et al.
2007/0080073	April 2007	Wu et al.
2008/0102441	May 2008	Chen et al.
2008/0145878	June 2008	Marfurt
2008/0149480	June 2008	Bell
2009/0014339	January 2009	Beer et al.
2009/0026094	January 2009	Deng et al.
2012/0211361	August 2012	Wu
2012/0298507	November 2012	Wu
2013/0240377	September 2013	Wu

Foreign Patent Documents


2423837	Oct 2000	CA
2358993	May 2001	CA
1322299	Oct 2000	CN
1328156	Dec 2001	CN
1598564	Oct 2004	CN
229500	Jun 1985	DE
271179	Aug 1989	DE
4003194	Aug 1991	DE
4100727	Jul 1992	DE
19944318891	Dec 1994	DE
19824629	Dec 1999	DE
69915850	Jan 2005	DE
34049	Aug 1981	EP
57110	Aug 1982	EP
120715	Oct 1984	EP
121385	Oct 1984	EP
127958	Dec 1984	EP
10375	Dec 1985	EP
164180	Dec 1985	EP
255291	Feb 1986	EP
206218	Dec 1986	EP
213343	Mar 1987	EP
215678	Mar 1987	EP
230472	Aug 1987	EP
241309	Oct 1987	EP
287883	Oct 1988	EP
330517	Feb 1989	EP
354441	Feb 1990	EP
359531	Mar 1990	EP
359831	Mar 1990	EP
383322	Aug 1990	EP
417796	Mar 1991	EP
470649	Feb 1992	EP
471986	Feb 1992	EP
537761	Apr 1993	EP
546536	Jun 1993	EP
546796	Jun 1993	EP
0628810	Dec 1994	EP
636880	Feb 1995	EP
640832	Mar 1995	EP
651250	May 1995	EP
186286	Jul 1996	EP
732406	Sep 1996	EP
732590	Sep 1996	EP
0741186	Nov 1996	EP
0762112	Mar 1997	EP
800086	Oct 1997	EP
837320	Apr 1998	EP
840122	May 1998	EP
851224	Jul 1998	EP
859230	Aug 1998	EP
878708	Nov 1998	EP
878713	Nov 1998	EP
887421	Dec 1998	EP
894509	Feb 1999	EP
942278	Sep 1999	EP
964059	Dec 1999	EP
1156324	Nov 2002	EP
1279742	Jan 2003	EP
1411348	Apr 2004	EP
2184236	Jan 2003	ES
2223185	Feb 2005	ES
2325920	Sep 1976	FR
2295676	Jun 1996	GB
62209350	Sep 1987	JP
3260739	Nov 1991	JP
09089832	Apr 1997	JP
11087213	Mar 1999	JP
2120657	May 1999	JP
2003028826	Jan 2003	JP
200361650	Mar 2003	JP
200403478	Jan 2004	JP
2004093478	Mar 2004	JP
2004300328	Oct 2004	JP
2005147990	Jun 2005	JP
WO 1981/001794	Jul 1981	WO
WO 1982/003729	Oct 1982	WO
WO 1983/000926	Mar 1983	WO
WO 1986/000138	Jan 1986	WO
WO 1986/002732	May 1986	WO
WO 1990/005293	May 1990	WO
WO 1990/005910	May 1990	WO
WO 1992/001928	Feb 1992	WO
WO 1992/007655	May 1992	WO
WO 1992/015704	Sep 1992	WO
WO 1992/015859	Sep 1992	WO
WO 1992/015861	Sep 1992	WO
WO 1992/015950	Sep 1992	WO
WO 1992/019961	Nov 1992	WO
WO 1992/022669	Dec 1992	WO
WO 1993/009433	May 1993	WO
WO 1993/21928	Nov 1993	WO
WO 1995/03542	Feb 1995	WO
WO 1995/007050	Mar 1995	WO
WO 1995/13535	May 1995	WO
WO 1995/13536	May 1995	WO
WO 1995/022597	Aug 1995	WO
WO 1996/004398	Feb 1996	WO
WO 1996/007908	Mar 1996	WO
WO 1996/013707	May 1996	WO
WO 1996/015454	May 1996	WO
WO 1996/014026	Oct 1996	WO
WO 1996/033403	Oct 1996	WO
WO 1997/000441	Jan 1997	WO
WO 1997/002487	Jan 1997	WO
WO 1997/008544	Mar 1997	WO
WO 1997/016726	May 1997	WO
WO 1997/018465	May 1997	WO
WO 1997/029366	Aug 1997	WO
WO 1997/029847	Aug 1997	WO
WO 1997/030344	Aug 1997	WO
WO 1997/039343	Oct 1997	WO
WO 1997/042882	Nov 1997	WO
WO 1997/042888	Nov 1997	WO
WO 1997/045719	Dec 1997	WO
WO 1998/005424	Feb 1998	WO
WO 1998/019153	May 1998	WO
WO 1998/019159	May 1998	WO
WO 1998/029740	Jul 1998	WO
WO 1998/044342	Oct 1998	WO
WO 1998/058246	Dec 1998	WO
WO 1998/058250	Dec 1998	WO
WO 1999/022227	May 1999	WO
WO 1999/22230	May 1999	WO
WO 1999/045375	Sep 1999	WO
WO 1999/67628	Dec 1999	WO
WO 2000/016089	Mar 2000	WO
WO 2000/020626	Apr 2000	WO
WO 2000/020855	Apr 2000	WO
WO 2000/029540	May 2000	WO
WO 2000/057011	Sep 2000	WO
WO 2000/077523	Dec 2000	WO
WO 2001/003207	Jan 2001	WO
WO 2001/033206	May 2001	WO
WO 2001/33216	May 2001	WO
WO 2001/056771	Aug 2001	WO
WO 2001/057510	Aug 2001	WO
WO 2001/057513	Aug 2001	WO
WO 2001/65246	Sep 2001	WO
WO 2001/67099	Sep 2001	WO
WO 2002/001214	Jan 2002	WO
WO 2002/031482	Apr 2002	WO
WO 2002/031481	Oct 2002	WO
WO 2002/077633	Oct 2002	WO
WO 2003/001195	Jan 2003	WO
WO 2003/069304	Feb 2003	WO
WO 2003/066554	Jun 2003	WO
WO 2003/087802	Oct 2003	WO
WO 2004/023128	Mar 2004	WO
WO 2004/040286	May 2004	WO
WO 2004/046707	Jun 2004	WO
WO 2004/053476	Jun 2004	WO
WO 2004/062801	Jul 2004	WO
WO 2004/113896	Dec 2004	WO
WO 2004/113912	Dec 2004	WO
WO 2004/113913	Dec 2004	WO
WO 2005/001462	Jan 2005	WO
WO 2005/001463	Jan 2005	WO
WO 2005/003748	Jan 2005	WO
WO 2005/008231	Jan 2005	WO
WO 2005/022143	Mar 2005	WO
WO 2005/040407	May 2005	WO
WO 2005/045234	May 2005	WO
WO 2005/078118	Aug 2005	WO
WO 2006/079797	Aug 2006	WO
WO 2006/110504	Oct 2006	WO

Other References

Dalrymple-Alford, P., et al., "Peak Shapes in Semi-differential Electroanalysis", "Anal. Chem.", 1977, pp. 1390-1394, vol. 49, No. 9, Publisher: American Chemical Society , Published in: USA. cited by applicant .
Hall, J.W. et al., "Automated Determination of Glucose using ENZ Glucose Oxidase and Potassium Ferrocyanide ENZ Peroxidase," Analytical Biochemistry, vol. 26, No. 1, 1968, pp. 12-17. cited by applicant .
PCT International Search Report dated Jun. 2, 2005, PCT/US2005/003622, 3 pages. cited by applicant .
Yao, et al., "A Thin-Film Glucose Electrode System with Compensation for Drifit", 1989, pp. 742-744, vol. XXXV. cited by applicant .
Yao, et al., "The Low-Potential Approach of Glucose Sensing", 1986, pp. 139-146, vol. BME-33, No. 2. cited by applicant.

Primary Examiner: Slawski; Magali P
Assistant Examiner: Carlson; Kourtney R S
Attorney, Agent or Firm: Nixon Peabody LLP

Parent Case Text

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of application Ser. No. 14/193,214 filed Feb. 28, 2014, which has been allowed; application Ser. No. 14/193,214 filed Feb. 28, 2014 is a division of application Ser. No. 10/590,867 filed Aug. 24, 2006, which has issued as U.S. Pat. No. 8,696,880; application Ser. No. 10/590,867 filed Aug. 24, 2006 is a nationalized application of Application No. PCT/US2005/03622 filed Feb. 4, 2005, which claims priority to Application No. 60/542,362 filed on Feb. 6, 2004, which are all incorporated by reference in their entireties.

Claims

What is claimed is:

1. A biosensor for determination of an analyte concentration in a fluid sample, the biosensor comprising: a working electrode; a counter electrode; and a mixture for electrochemical reaction with an analyte, the mixture including the enzyme, a mediator, and an oxidizable species as an internal reference, the mediator being ferricyanide, the oxidizable species being ferrocyanide, the ferrocyanide being from 0.1 to 1% of the total ferricyanide, the mixture being located as a single layer directly on a surface of at least a portion of the working electrode prior to the introduction of the fluid sample, the mixture including only one enzyme.

2. The biosensor of claim 1, wherein the enzyme comprises glucose oxidase.

3. The biosensor of claim 1, wherein the mixture is located as a single layer directly on a surface of at least a portion of the counter electrode prior to the introduction of the fluid sample.

4. A method of forming and applying a reagent mixture for an electrochemical reaction with an analyte of a fluid sample in a biosensor, the biosensor having a working electrode and a counter electrode, the method the acts of comprising: forming a batch of the reagent mixture by adding an enzyme, adding a mediator and adding a known amount of an oxidizable species, the added oxidizable species being added separately from the mediator, the mediator being ferricyanide, the oxidizable species being ferrocyanide; and after forming the reagent mixture, placing the reagent mixture directly on a surface of at least a portion of the working electrode of the biosensor prior to the introduction of the fluid sample, the mixture including only one enzyme.

5. The method of claim 4, wherein the enzyme comprises glucose oxidase.

6. The method of claim 4, wherein the mixture is located as a single layer directly on a surface of at least a portion of the counter electrode prior to the introduction of the fluid sample.

7. A method of using a biosensor to assist in determining glucose concentration of a fluid sample, the method comprising: providing a biosensor including a working electrode, a counter electrode and a reagent, the reagent located directly on a surface of at least a portion of the working electrode prior to introduction of the test sample, the reagent including an enzyme, a mediator and an oxidizable species as an internal reference, the mediator being ferricyanide, the oxidizable species being ferrocyanide, the ferrocyanide being from 0.1 to 1% of the total ferricyanide; applying a first voltage potential in a first voltage period; providing a set delay period; and applying a second voltage potential in a second voltage period following the delay period.

8. The method of claim 7, wherein the enzyme comprises glucose oxidase.

9. The method of claim 7, wherein the mixture is located as a single layer directly on a surface of at least a portion of the counter electrode prior to the introduction of the fluid sample.

Description

FIELD OF THE INVENTION

The present invention generally relates to a biosensor, and, more particularly, to a new and improved biosensor, including an oxidizable species as an internal reference and methods of use of the biosensor, for determining the presence or amount of a substance in a sample.

DESCRIPTION OF THE PRIOR ART

The quantitative determination of analytes in body fluids is of great importance in the diagnoses and maintenance of certain physiological abnormalities. For example lactate, cholesterol and bilirubin should be monitored in certain individuals. In particular, the determination of glucose in body fluids is of great importance to diabetic individuals who must frequently check the level of glucose in their body fluids as a means of regulating the glucose intake in their diets. While the remainder of the disclosure herein will be directed towards the determination of glucose, it is to be understood that the new and improved sensor element and method of use of this invention can be used for the determination of other analytes upon selection of the appropriate enzyme.

Methods for determining analyte concentration in fluids can be based on the electrochemical reaction between the analyte and an enzyme specific to the analyte and a mediator which maintains the enzyme in its initial oxidation state. Suitable redox enzymes include oxidases, dehydrogenases, catalase and peroxidase. For example, in the case where glucose is the analyte, the reaction with glucose oxidase and oxygen is represented by equation:

##STR00001##

In the initial step of the reaction represented by equation (A), glucose present in the test sample converts the enzyme (E.sub.ox), such as the oxidized flavin adenine dinucleotide (FAD) center of the enzyme into its reduced form (E.sub.red), for example, (FADH.sub.2). Because these redox centers are essentially electrically insulated within the enzyme molecule, direct electron transfer to the surface of a conventional electrode does not occur to any measurable degree in the absence of an unacceptably high cell voltage. An improvement to this system involves the use of a nonphysiological redox coupling between the electrode and the enzyme to shuttle electrons between the (FADH.sub.2) and the electrode. This is represented by the following scheme in which the redox coupler, typically referred to as a mediator, is represented by M: Glucose+GO(FAD).fwdarw.gluconolactone+GO(FADH.sub.2) GO(FADH.sub.2)+2M.sub.ox.fwdarw.GO(FAD)+2M.sub.red+2H.sup.+ 2M.sub.red.fwdarw.2M.sub.ox+2e.sup.-(at the electrode)

In the scheme, GO(FAD) represents the oxidized form of glucose oxidase and GO(FAD H.sub.2) indicates its reduced form. The mediating species M.sub.ox/M.sub.red shuttles electrons from the reduced enzyme to the electrode thereby oxidizing the enzyme causing its regeneration in situ.

U.S. Pat. Nos. 5,620,579 and 5,653,863 issued to Genshaw et al., and assigned to the present assignee, disclose apparatus and method for determining the concentration of an analyte in a fluid test sample by applying the fluid test sample to the surface of a working electrode, which is electrochemically connected to a counter electrode, and which surface bears a composition comprising an enzyme specific for the analyte. A mediator is reduced in response to a reaction between the analyte and the enzyme. An oxidizing potential is applied between the electrodes to return at least a portion of the mediator back to its oxidized form before determining the concentration of the analyte to thereby increase the accuracy of the analyte determination. Following this initially applied potential, the circuit is switched to an open circuit or to a potential that substantially reduces the current to minimize the rate of electrochemical potential at the working electrode. A second potential is applied between the electrodes and the current generated in the fluid test sample is measured to determine analyte concentration. Optionally, the accuracy of the analyte determination is further enhanced algorithmically.

SUMMARY OF THE INVENTION

Important aspects of the present invention are to provide a new and improved biosensor for determining the presence or amount of a substance in a sample including an oxidizable species as an internal reference and method of use of the biosensor.

In brief, a biosensor for determining the presence or amount of a substance in a sample and methods of use of the biosensor are provided. The biosensor for receiving a user sample to be analyzed includes a mixture for electrochemical reaction with an analyte. The mixture includes an enzyme, a mediator and an oxidizable species as an internal reference.

The internal reference is defined as the oxidizable species which in one embodiment can be further defined as the reduced form of a reversible redox couple that has an equal or higher redox potential than that of the mediator. The internal reference acts to increase the response current additively for operation potentials that oxidize both species and in the case where glucose is the analyte, a total response current is represented by: I.sub.total=I.sub.int-ref+I.sub.glucose I.sub.int-ref.varies.(internal reference) and I.sub.glucose.varies.(glucose); Where I.sub.int-ref is the portion of the total response current due to the internal reference, while I.sub.glucose is due to the oxidation of mediator proportional to the glucose concentration.

In accordance with features of the invention, the internal reference can be either the same mediator species or an oxidizable species with a higher redox potential than the mediator. Thus for biosensors with a low operation potential oxidizing only the mediator, the current I.sub.int-ref will be zero. However, for biosensors with a higher operation potential that oxidizes both species, the total response current will be the sum of the portion due to internal reference and that due to glucose. Since the internal reference concentration is fixed, the calibration slope of the sensor will only depend on the sensor response for glucose while the intercept will depend on the added amount of the internal reference. In another words, the internal reference will only offset the intercept and will not change the calibration slope. Thus, the concept of internal reference provides new and different ways to make glucose biosensors.

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention together with the above and other objects and advantages may best be understood from the following detailed description of the preferred embodiments of the invention illustrated in the drawings, wherein:

FIG. 1A is a block diagram representation of biosensor meter including a biosensor having an internal reference in accordance with the present invention;

FIGS. 1B, 1C, and 1D are diagrams respectively illustrating operational methods for use with the biosensor of FIG. 1 of the invention;

FIGS. 2A, 2B, and 2C are charts showing three cyclic voltammograms of MLB based glucose biosensors with ferrocyanide as the internal reference the biosensor of FIG. 1 of the invention in whole blood samples of 0 mg/dL glucose;

FIG. 3 is a chart illustrating a linear response of the biosensor of FIG. 1 of the invention at different voltage operating potentials;

FIG. 4 is a chart illustrating effect of the added internal reference to the overall voltammetric current using biosensors of FIG. 1 of the invention with 10% printed ferricyanide as the counter electrode;

FIGS. 5A and 5B are charts illustrating linear response and increased intercept with increasing internal reference of MLB based biosensors of FIG. 1 of the invention with Ag/AgCl as the counter electrode;

FIGS. 6A and 6B are charts illustrating linear response and increased intercept with increasing internal reference of MLB based biosensors of FIG. 1 of the invention with 10% ferricyanide as the counter electrode;

FIG. 7 is a chart illustrating linear relationship of the calibration intercept with increasing internal reference of DEX biosensors of FIG. 1 of the invention with 10% ferricyanide as the counter electrode; and

FIGS. 8A and 8B are charts illustrating the ratio of signal to reference results from flow-injection-analysis (FIA) of the residual ferrocyanide from a control reagent ink and the reagent ink with 0.1% ferrocyanide added to the reagent mixture of 20% ferricyanide of a biosensor of FIG. 1 of the invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention relates to an electrochemical biosensor for determining the presence or amount of a substance in a sample. The biosensor includes sensor strips containing a working electrode and a counter electrode, each of which is at least partially covered with, for example, a separate reagent layer. The reagent layer on the working electrode includes, for example, an enzyme that interacts with an analyte through an oxidation-reduction reaction and also includes a mediator that is the oxidized form of a redox couple. The biosensor of the invention includes an internal reference or a reduced form of the mediator in the reagent layer on the working electrode. The internal reference is defined as an oxidizable species which in one embodiment can be further defined as a reduced form of a reversible redox couple that has an equal or higher redox potential than that of the mediator. A fixed quantitative amount of the internal reference is provided in the reagent layer. The biosensors of the invention including the internal reference or added amount of the reduced form of mediator provide for improvements in that the internal reference acts to anchor the calibration intercept by nature of thermodynamics while maintaining the calibration slope.

Many compounds are useful as mediators due to their ability to accept electrons from the reduced enzyme and transfer them to the electrode. A necessary attribute of a mediator is the ability to remain in the oxidized state under the conditions present on the electrode surface prior to the use of the sensor. Among the more venerable mediators are the oxidized form of organometallic compounds, organic molecules, transition metal coordination complexes. A specific example of mediator is the potassium hexacyanoferrate (III), also known as ferricyanide.

As used in the following specification and claims, the term biosensor means an electrochemical sensor strip or sensor element of an analytical device or an instrument that responds selectively to analytes in an appropriate sample and converts their concentration into an electrical signal. The biosensor generates an electrical signal directly, facilitating a simple instrument design. Also, a biosensor offers the advantage of low material cost since a thin layer of chemicals is deposited on the electrodes and little material is wasted.

The term "sample" is defined as a composition containing an unknown amount of the analyte of interest. Typically, a sample for electrochemical analysis is in liquid form, and preferably the sample is an aqueous mixture. A sample may be a biological sample, such as blood, urine or saliva. A sample may be a derivative of a biological sample, such as an extract, a dilution, a filtrate, or a reconstituted precipitate.

The term "analyte" is defined as a substance in a sample, the presence or amount of which is to be determined. An analyte interacts with the oxidoreductase enzyme present during the analysis, and can be a substrate for the oxidoreductase, a coenzyme, or another substance that affects the interaction between the oxidoreductase and its substrate.

The term "oxidoreductase" is defined as any enzyme that facilitates the oxidation or reduction of a substrate. The term oxidoreductase includes "oxidases," which facilitate oxidation reactions in which molecular oxygen is the electron acceptor; "reductases," which facilitate reduction reactions in which the analyte is reduced and molecular oxygen is not the analyte; and "dehydrogenases," which facilitate oxidation reactions in which molecular oxygen is not the electron acceptor. See, for example, Oxford Dictionary of Biochemistry and Molecular Biology, Revised Edition, A. D. Smith, Ed., New York: Oxford University Press (1997) pp. 161, 476, 477, and 560.

The term "oxidation-reduction" reaction is defined as a chemical reaction between two species involving the transfer of at least one electron from one species to the other species. This type of reaction is also referred to as a "redox reaction." The oxidation portion of the reaction involves the loss of at least one electron by one of the species, and the reduction portion involves the addition of at least one electron to the other species. The ionic charge of a species that is oxidized is made more positive by an amount equal to the number of electrons transferred. Likewise, the ionic charge of a species that is reduced is made less positive by an amount equal to the number of electrons transferred.

The term "oxidation number" is defined as the formal ionic charge of a chemical species, such as an atom. A higher oxidation number, such as (III), is more positive, and a lower oxidation number, such as (II), is less positive. A neutral species has an ionic charge of zero. Oxidation of a species results in an increase in the oxidation number of that species, and reduction of a species results in a decrease in the oxidation number of that species.

The term "redox pair" is defined as two species of a chemical substance having different oxidation numbers. Reduction of the species having the higher oxidation number produces the species having the lower oxidation number. Alternatively, oxidation of the species having the lower oxidation number produces the species having the higher oxidation number.

The term "oxidizable species" is defined as the species of a redox pair having the lower oxidation number, and which is thus capable of being oxidized into the species having the higher oxidation number. Likewise, the term "reducible species" is defined as the species of a redox pair having the higher oxidation number, and which is thus capable of being reduced into the species having the lower oxidation number.

The term "organotransition metal complex," also referred to as "OTM complex," is defined as a complex where a transition metal is bonded to at least one carbon atom through a sigma bond (formal charge of -1 on the carbon atom sigma bonded to the transition metal) or a pi bond (formal charge of 0 on the carbon atoms pi bonded to the transition metal). For example, ferrocene is an OTM complex with two cyclopentadienyl (Cp) rings, each bonded through its five carbon atoms to an iron center by two pi bonds and one sigma bond. Another example of an OTM complex is ferricyanide (III) and its reduced ferrocyanide (II) counterpart, where six cyano ligands (formal charge of -1 on each of the 6 ligands) are sigma bonded to an iron center through the carbon atoms of the cyano groups.

The term "coordination complex" is defined as a complex having well-defined coordination geometry, such as octahedral or square planar geometry. Unlike OTM complexes, which are defined by their bonding, coordination complexes are defined by their geometry. Thus, coordination complexes may be OTM complexes (such as the previously mentioned ferricyanide), or complexes where non-metal atoms other than carbon, such as heteroatoms including nitrogen, sulfur, oxygen, and phosphorous, are datively bonded to the transition metal center. For example, ruthenium hexaamine, or hexaaminoruthenate (II)/(III), is a coordination complex having a well-defined octahedral geometry where six NH.sub.3 ligands (formal charge of 0 on each of the 6 ligands) are datively bonded to the ruthenium center. Ferricyanide is also an example of the coordination complex that has the octahedral geometry. A more complete discussion of organotransition metal complexes, coordination complexes, and transition metal bonding may be found in Collman et al., Principles and Applications of Organotransition Metal Chemistry (1987) and Miessler & Tarr, Inorganic Chemistry (1991).

The term "mediator" is defined as a substance that can be oxidized or reduced and that can transfer one or more electrons between a first substance and a second substance. A mediator is a reagent in an electrochemical analysis and is not the analyte of interest. In a simplistic system, the mediator undergoes a redox reaction with the oxidoreductase after the oxidoreductase has been reduced or oxidized through its contact with an appropriate substrate. This oxidized or reduced mediator then undergoes the opposite reaction at the electrode and is regenerated to its original oxidation number.

The term "electroactive organic molecule" is defined as an organic molecule that does not contain a metal and that is capable of undergoing an oxidation or reduction reaction. Electroactive organic molecules can behave as redox species and as mediators. Examples of electroactive organic molecules include coenzyme pyrroloquinoline quinone (PQQ), benzoquinones and naphthoquinones, N-oxides, nitroso compounds, hydroxylamines, oxines, flavins, phenazines, phenothiazines, indophenols, and indamines.

The term "electrode" is defined as an electrically conductive substance that remains stationary during an electrochemical analysis. Examples of electrode materials include solid metals, metal pastes, conductive carbon, conductive carbon pastes, and conductive polymers.

Having reference now to the drawings, in FIG. 1 there is illustrated a biosensor meter designated as a whole by the reference character 100 of the preferred embodiment and arranged in accordance with principles of the present invention. Biosensor meter 100 includes a biosensor 102 arranged in accordance with principles of the present invention. Biosensor meter 100 includes microprocessor 104 together with an associated memory 106 for storing program and user data. Digital data from the microprocessor 104 is applied to a digital-to-analog (D/A) converter 108. D/A converter 108 converts the digital data to an analog signal. An amplifier 110 coupled to the D/A converter 108 amplifies the analog signal. The amplified analog signal output of amplifier 110 is applied to the biosensor 102 of the invention. Biosensor 102 is coupled to an amplifier 112. The amplified sensed signal is applied to an analog-to-digital (A/D) converter 114 that converts the amplified, analog sensor signal to a digital signal. The digital signal is applied to the microprocessor 104.

Most of the commercially available disposable biosensors used for monitoring blood glucose require the deposition/printing of a mixture of an enzyme and a mediator with some binding agent. For the application of glucose measurement, the mediator is in the oxidized form of a redox couple. Depending on the redox couple, the mediator can be a very strong oxidant, such as ferricyanide, thereby chemically oxidizing the functional groups after mixing with the enzyme and the binding agent. Subsequently, a small amount of the reduced mediator is formed as impurity in the reagent in the processes of ink mixing, storage and printing. Thus, the end result of mixing and printing the reagent ink is the generation of the reduced form of the redox couple, giving rise to the background current. The formation of this reduced form of the mediator and thus the background current may vary from batch to batch. This process-generated reduced form of the mediator, such as ferrocyanide from ferricyanide, can be oxidized in general to minimize the background signal using the algorithm outlined in the U.S. Pat. Nos. 5,620,579 and 5,653,863, to Genshaw et al., and assigned to the present assignee. However, the process-dependent background signal, which is translated into the calibration intercept, can be spread out in a range of values. At the extremes of these diverged values of intercept, analytical accuracy will be suffered because no reasonable calibration intercept can be assigned to accommodate the diverged intercept.

In accordance with features of the invention, a grade of mediator that contains a certain level of the reduced form of the mediator in the reagent is used for decreasing the effect of the strong oxidant. Thermodynamically, the presence of a small amount of the reduced form of the mediator in the ink mixture of enzyme and mediator decreases the driving force for the conversion from the oxidized to the reduced form. This is advantageously accomplished by adding a small fixed amount of the reduced form of the mediator to the oxidized mediator.

Even though background signal will be generated, the algorithm in the U.S. Pat. Nos. 5,620,579 and 5,653,863 will minimize the effect of background to increase the accuracy of the glucose sensor. The above-identified patents disclose a method that reduces the background bias due to oxidizable impurities in an amperometric sensor used for measuring a specific analyte, such as glucose, in blood. The background current of such a sensor will increase if it is stored over a long period of time or under stress (heat, moisture, etc.) due to the increased presence of reduced mediator or other reduced impurity present in the sensor such as enzyme stabilizers, e.g. glutamate, and surfactants having reducing equivalents. For example, in a ferricyanide based amperometric sensor, the background bias is related to the presence of ferrocyanide (from the reduction of ferricyanide) near the electrode surface. This accumulated ferrocyanide, as opposed to the ferrocyanide produced during use of the sensor (fresh ferrocyanide), is oxidized back to ferricyanide to reduce the background bias it causes and thereby extend the sensor shelf life. To achieve this objective, the method uses an electrochemical approach. The background bias is further reduced when the electrochemical approach is augmented with an algorithmic correction.

The disclosed method involves first applying a positive potential pulse (called the "burn-off" pulse) which precedes the normal potential profile during use of the biosensor. This is typically accomplished by applying a positive potential of from 0.1 to 0.9 volt (preferably 0.3 to 0.7 volt) between the working and reference electrodes of the sensor for a period of from 1 to 15 seconds (preferably 5 to 10 seconds). The burn-off pulse oxidizes the initial ferrocyanide (or other oxidizable impurity), so that the sensor can begin the assay with a clean background. Typically, the background is not perfectly clean since only a portion of the oxidizable impurity is oxidized by the burn-off pulse. This is the case because the chemical layer covers both the working and the counter electrodes. The initial ferrocyanide exists in the chemical layer since it comes from ferricyanide. When sample fluid is applied and the chemical layer re-hydrates, the ferrocyanide near the working electrode is re-oxidized. The rest of the ferrocyanide diffuses into the sample fluid and is mixed with the glucose. That portion of the initial ferrocyanide cannot be re-oxidized without affecting the glucose. The initial ferrocyanide is near the electrode for a very short time (a few seconds) after the fluid test sample is applied. The reason for this is that the chemicals (enzyme and ferricyanide, etc.) are deposited as a thin layer on the working and counter electrodes. The burn-off technique takes advantage of this since a significant amount of the initial ferrocyanide can be burned off without noticeable reduction of the analyte concentration in the fluid test sample most of which does not come into direct contact with the electrode. Experiments have demonstrated that the background bias of a stressed sensor can be reduced by 40% with proper application of the burn-off pulse.

The disclosed method of the U.S. Pat. Nos. 5,620,579 and 5,653,863 advantageously is applied to minimize the effect of background signal to increase the accuracy of the glucose biosensor meter 100 of the preferred embodiment. The subject matter of the above-identified patents is incorporated herein by reference.

In accordance with features of the invention, the added amount of the reduced form of mediator acts to anchor the calibration intercept by nature of thermodynamics while maintaining the calibration slope. In light of the function the reduced form of mediator, for example, ferrocyanide, plays in the glucose sensor, it is referred to as the internal reference.

Examples of electroactive organic molecule mediators are described in U.S. Pat. No. 5,520,786, issued to Bloczynski et al. on May 28, 1996, and assigned to the present assignee. In particular, a disclosed mediator (compound 18 in TABLE 1) comprising 3-phenylimino-3H-phenothiazine referred to herein as MLB-92, has been used to make a glucose biosensor 102 in accordance with features of the invention. The subject matter of the above-identified patent is incorporated herein by reference.

A commercially available biosensor meter and biosensor is manufactured and sold by Bayer Corporation under the trademark Ascensia DEX. The Ascensia DEX biosensor includes generally as pure a form of ferricyanide as possible for the reagent. The Ascensia DEX biosensor has been used to make a glucose biosensor 102 in accordance with features of the invention by adding an adequate amount of ferrocyanide to the pure ferricyanide. Benefits of adding ferrocyanide defining the internal reference of biosensor 102 to the Ascensia DEX reagent ink include an immediate benefit of increasing the intercept without changing slope, anchoring the intercept range, and increasing long-term stability of biosensor during storage.

In accordance with features of the invention, the MLB-92 mediator having a lower redox potential was used to make a glucose biosensor 102 with special properties. With the addition of adequate amounts of the internal reference, ferrocyanide, the new biosensor system can be made to work with two operation potentials: (1) at 400 mV where both the new mediator and the internal reference are oxidized, and (2) at 100 mV where only the new mediator can be oxidized. The significance of this approach is two-fold. First, the glucose biosensor 102 such formulated (new mediator and internal reference) can be operated at a high potential (+400 mV) to produce currents in a range that fits the calibration characteristics of the hardware requirements of the existing instrument. Secondly, since the lower redox potential and thus a lower oxidation power of the mediator will likely to have virtually no conversion of the oxidized form to the reduced form of the mediator, a lower operation potential (0-100 mV) can be applied to the sensor so as to avoid the oxidation of the internal reference. Thus, a new set of calibration characteristics based on the new mediator, most likely with near zero intercept due to the lower oxidation power, will lead to a better analytical precision for glucose measurements. It will also reduce the matrix interference in the whole blood by avoiding the oxidation of some of the known oxidizable species such as uric acid and acetaminophen.

In accordance with features of the invention, another application of the internal reference to glucose sensors 102 is to add adequately large amount of internal reference to the biosensor system to produce a high current response. Using the double steps algorithm with open circuit between them (Bayer U.S. Pat. Nos. 5,620,579 and 5,653,863), the first potential step is set at 400 mV to produce a current that is mostly due to the internal reference signal while the second step is set at a low potential (0-100 mV) to produce a current signal related to the glucose concentration only. The ratio of the first signal, which should be virtually independent of the whole blood hematocrit, to the second signal at low potential can be used to correct for the analytical bias due to hematocrit effect.

In accordance with features of the invention, the internal reference is defined as the oxidizable species which in one embodiment is further defined as the reduced form of a reversible redox couple that has an equal or higher redox potential than that of the mediator. The concept and use of an internal reference are very common in the field of analytical chemistry. However, no example of using an internal reference for biosensors has been suggested in existing patents or literature. In all three scenarios described above, the internal reference acts to increase the response current additively for operation potentials that oxidize both species and with glucose as the analyte; a total response current is represented by: I.sub.total=I.sub.int-ref+I.sub.glucose I.sub.int-ref.varies.(internal reference) and I.sub.glucose.varies.(glucose); Where I.sub.int-ref is the portion of the total response current due to the internal reference, while I.sub.glucose is due to the oxidation of mediator proportional to the glucose concentration.

In accordance with features of the invention, the internal reference can be either the same mediator species or an oxidizable species with a higher redox potential than the mediator. Thus for biosensors with a low operation potential oxidizing only the mediator, the current I.sub.int-ref will be zero. However, for biosensors with a higher operation potential that oxidizes both species, the total response current will be the sum of the portion due to internal reference and that due to glucose. Since the internal reference concentration is fixed, the calibration slope of the sensor will only depend on the sensor response for glucose while the intercept will depend on the added amount of the internal reference. In another words, the internal reference will only offset the intercept and will not change the calibration slope. Thus, the concept of internal reference provides new and different ways to make glucose biosensors.

Referring now to FIGS. 1B, 1C, and 1D, there are at least three modes of operation based on the use of internal reference for glucose biosensors 102 of the invention. Potentiostatically, the three of modes of operation are represented in FIGS. 1B, 1C, and 1D. Each of the illustrated modes of operation include a first burnoff pulse, followed by a second wait period or open circuit, and a final third read pulse, each pulse or period having a selected duration, for example, 10 seconds. In the basic and most immediate operation, ferrocyanide is retained in ferricyanide at the concentration of 0.1 to 1% of the total ferricyanide providing the internal reference for glucose biosensors 102 of the invention. This is depicted in FIG. 1B where both potentials in the first and the third periods are at the same voltage, for example 400 mV. Retaining of a small percentage of ferrocyanide defining the internal reference can be accomplished either by an appropriate purification process of ferricyanide or by adding an adequate amount of ferrocyanide to the pure ferricyanide. The outcome of these retaining processes is to keep deliberately a desirable amount of ferrocyanide in ferricyanide as a special grade of ferricyanide. This is in contrast to the conventional wisdom of having as pure a form of ferricyanide as possible, such as for the DEX reagent, usually ferrocyanide in the order of 0.05% of ferricyanide or less as impurity. The most desirable amount is 0.1% ferrocyanide in the final formulation for DEX sensor, which will lead to the anchoring of the calibration intercept at a narrower range while maintaining the calibration slope for the DEX sensor.

In FIG. 1C the second mode of operation is shown, where a desirable amount of ferrocyanide (the internal reference) is added to the reagent of enzyme and a mediator with a redox potential lower than that of the internal reference. The biosensor 102 is expected to work under high and low potentials (for example at 400 mV and 100 mV vs. Ag/AgCl) for existing instruments and instruments with a new hardware requirement. This biosensor can be operated in potential programs depicted in FIG. 1B for existing instruments 100 and FIG. 1C for new instruments 100. Examples of the mediator and internal reference combination include the system of MLB-92 and ferrocyanide as well as ruthenium hexaamine and ferrocyanide. The separation of the two redox potentials is large enough so that there will be generally no oxidation of the internal reference species when operated at the low voltage.

In FIG. 1D the third mode of operation is shown, where a higher but desirable concentration of ferrocyanide is added to the reagent mixture of enzyme and a mediator with a redox potential lower than that of the internal reference. The amount of the internal reference would produce a current equivalent to about 50% to 75% of the full scale in the calibration range preferably. In the operation algorithm, the first potential step is set to oxidize both the mediator and the internal reference (400 mV) while the second potential step for the read pulse is to oxidize the mediator only (0-100 mV). The current in the first potential step of FIG. 1D will be most pertinent to the internal reference that is immediately next to the electrode and should have virtually no hematocrit effect. The ratio of the current from the second step to that from the first step will provide a correction for the analytical bias due to hematocrit effect.

Experiments have been carried out to show the feasibility of the method of adding internal reference to a mediator system to overcome existing problems or to enhance sensor performance in accordance with the biosensor 102 of the invention.

Referring now to FIGS. 2A, 2B, and 2C, there are shown three cyclic voltammograms illustrating operation of the biosensor 102 of the invention. The illustrated three cyclic voltammograms are for MLB based glucose biosensors 102 with ferrocyanide as the internal reference in whole blood samples of 0 mg/dL glucose.

FIG. 2A illustrates working electrode vs. ferricyanide counter electrode, FIG. 2B illustrates working electrode vs. silver (Ag) and silver chloride (AgCl) or Ag/AgCl counter electrode and FIG. 2C illustrates working electrode vs. MLB-92 counter electrode. Respective peaks labeled 1 and 2 represent the oxidation of the mediator MLB.sub.red (reduced form of MLB) and the internal reference ferrocyanide respectively for all three voltammogram plots. The oxidation peak for MLB.sub.red shifts along the potential scale as the redox couple on the counter electrode changes from ferricyanide to Ag/AgCl to MLB-92. However, it can be seen that the relative position of the mediator MLB-92 to the internal reference ferrocyanide is the same in all three voltammogram plots of FIGS. 2A, 2B, and 2C.

Referring to FIG. 3, there shown in FIG. 3 is a chart illustrating a linear response of the biosensor 102 of the invention at different voltage operating potentials. The biosensor 102 is operated at (1) 400 mV potential and (2) 150 mV potential. FIG. 3 illustrates the linear dose response of MLB-92 mediator based biosensor 102 with 20 mM ferrocyanide as the internal reference. Respective lines labeled EXAMPLE 1 and EXAMPLE 2 are from 400 mV and 150 mV operation potentials against Ag/AgCl counter electrode. As shown in FIG. 3, the biosensor 102 gives virtually the same slope but with different intercepts for operations at 400 mV and 150 mV potentials. This result demonstrates that the internal reference can be selectively oxidized or avoided by the operation potential. Thus, one biosensor 102 can serve for two different meters.

Examples of the biosensor 102 have been prepared systematically showing the increase of intercept with increasing ferrocyanide as the internal reference while the slopes were kept virtually unchanged. Three working electrode reagents were prepared in the following formulations. These three reagents were pin-deposited on to two sensor formats: (1) Ag/AgCl as the counter electrode, (2) 10% printed ferricyanide as the counter electrode.

TABLE-US-00001 Enzyme, Internal PQQ- Mediator Reference Buffer and Formulations GDH MLB-92 Ferricyanide binding agent, 1 20 unit/.mu.L 24 mM 0 mM 0.1M NaCl + phosphate, 1% CMC 2 20 unit/.mu.L 24 mM 4 mM 0.1M NaCl + phosphate, 1% CMC 3 20 unit/.mu.L 24 mM 8 mM 0.1M NaCl + phosphate, 1% CMC

FIG. 4 illustrates effect of the added internal reference to the overall voltammetric current using biosensors 102 of the invention with 10% printed ferricyanide as the counter electrode. FIG. 4 provides cyclic voltammograms of sensors with ferrocyanide as the internal reference in whole blood samples of 0 mg/L glucose. Voltammograms labeled A, B and C are with formulations 1, 2 and 3 respectively all with a counter electrode of 10% printed ferricyanide.

The effect of the added internal reference to the overall voltammetric current is shown in FIG. 4 using sensors with 10% printed ferricyanide as the counter electrode. The main oxidation/reduction peaks here are centered around -0.38 Volt vs. 10% ferricyanide, which is due to the mediator MLB. The oxidation peak at about 0-50 mV is due to the internal reference of ferrocyanide. While the oxidation peak for the internal reference ferrocyanide increases with the increases of the internal reference concentration from 0 to 4 to 8 mM, the oxidation peak for the mediator is virtually unchanged. Here the concept of internal reference is explained further by the fact that the main oxidation peak of MLB.sub.red is unaffected by the presence of the internal reference.

Referring to FIGS. 5A and 5B, charts illustrating linear response and increased intercept with increasing internal reference of MLB based biosensors 102 of the invention with Ag/AgCl as the counter electrode are shown. FIG. 5A illustrates the linear dose response of MLB based biosensors 102 with 0, 4, and 8 mM ferrocyanide, respectively labeled EXAMPLE 1, EXAMPLE 2, and EXAMPLE 3. FIG. 5B illustrates intercept and slope as a function of added ferrocyanide in the working electrode reagent of the biosensor 102 of the invention. All three sensors used Ag/AgCl as the counter electrode.

Referring also to FIGS. 6A and 6B, charts illustrating linear response and increased intercept with increasing internal reference of MLB based biosensors 102 of the invention with 10% ferricyanide as the counter electrode are shown. FIG. 6A illustrates the linear dose response of MLB based biosensors 102 with 0, 4, and 8 mM ferrocyanide, respectively labeled EXAMPLE 1, EXAMPLE 2, and EXAMPLE 3. FIG. 6B illustrates intercept and slope as a function of added ferrocyanide in the working electrode reagent of the biosensor 102 of the invention. All three sensors used 10% printed ferricyanide as the counter electrode.

In the dose response experiments, both sensor series with Ag/AgCl counter electrode of FIGS. 5A and 5B, and 10% ferricyanide counter electrode of FIGS. 6A and 6B show linear response and increased intercept with increasing internal reference. For practical purpose, the slope of the three sensors in FIGS. 5A and 5B is unchanged while the intercept increases linearly with the added ferrocyanide. The same linear relationship of intercept with added ferrocyanide and the flat slope trend are repeated in sensor series with the % printed ferricyanide as the counter electrode, as shown in FIGS. 6A and 6B.

Experiments have been carried out to show the addition of ferrocyanide to DEX reagent ink, modification of calibration intercept without changing slope in accordance with the biosensor 102 of the invention.

FIG. 7 illustrates linear relationship of the calibration intercept with increasing internal reference of DEX type biosensors 102 of the invention. Five different formulations in a set format labeled BC7 in FIG. 7 were made with 0, 0.02, 0.04, 0.06 and 0.08% ferrocyanide mixed in the standard DEX reagent for the DEX sensor. The regression slope and intercepts for these five sensors of the BC7 format are shown in FIG. 7. Except for sensor with 0.06% ferrocyanide due to the experimental problems, the intercepts of the other four sensors give a nice linear function with respect to the added amount of ferrocyanide as the internal reference. On the other hand, the slopes of all five sensors fall in a flat line indicating that the addition of the internal reference does not change the slope of the DEX type biosensors 102 of the invention.

FIGS. 8A and 8B illustrate the ratio of signal to reference results from flow-injection-analysis (FIA) of the residual ferrocyanide from a control reagent ink and the reagent ink with 0.1% ferrocyanide added to the reagent mixture of 20% ferricyanide of a biosensor 102 of the invention. One of the subtle effects of adding the internal reference ferrocyanide to the DEX reagent ink is to decrease the driving force for the conversion of the mediator ferricyanide to ferrocyanide. Thus, ferricyanide becomes the source of the residual current in the DEX sensor. One way of showing this subtle effect is to monitor the increase of the residual current (background current) of the reagent ink with internal reference along with the control reagent ink over a long period of time. Both reagent inks were stored in refrigeration (2-8.degree. C.) over several weeks. FIG. 8 shows the results of FIA of the residual ferrocyanide from both reagent inks. From FIG. 8, the ratio of signal-to-reference (S/R) represents the relative amount of ferrocyanide from the reagent ink compared to the added ferrocyanide as the reference in FIA. Thus, the higher the value of S/R from the FIA analysis, the higher the ferrocyanide in the reagent inks. It can be seen from FIG. 8A that the S/R value increase over the period of six weeks for both the control inks and the reagent ink with added ferrocyanide. However, the reagent ink curve with added ferrocyanide has a slower increase of residual current over the period of six weeks compared to control curves. In FIG. 8B, the S/R response curves from the control inks and the reagent ink with added ferrocyanide are merged together for comparison. To the first order approximation (since the coefficients for the second order terms of both second order polynomials are very small), the rate of residual current increase over six weeks during refrigeration is about 30% ([0.0918-0.0638]/0.0918=30%) smaller for the reagent ink curve with added ferrocyanide than for the control curves. Thus, it may be understood from FIGS. 8A and 8B that the rate of the ferricyanide-to-ferrocyanide conversion in reagent ink is decreased substantially by the addition of the internal reference ferrocyanide to the DEX reagent ink in accordance with biosensor 102 of the invention.

While the present invention has been described with reference to the details of the embodiments of the invention shown in the drawings, these details are not intended to limit the scope of the invention as claimed in the appended claims.

* * * * *